K-STREET TRACKER
FOLLOW THE MONEY INTO THE SWAMP
Every federal lobbying filing tagged with a public-company ticker — who is spending, which firms they hire, and which members trade right around the filing.
Filings tracked
19,882
thru 2026-05-08
Total reported $
$2.7B
disclosed lobbying
Distinct clients
2,220
paying companies
Tickers targeted
1,207
public companies
💸 Top Spending Clients
| # | Client | Filings | Total $ |
|---|---|---|---|
| 1 |  PFIZER INC.PFE | 47 | $46.8M |
| 2 |  GENERAL MOTORS COMPANYGM | 61 | $46.8M |
| 3 |  META PLATFORMS INC. AND VARIOUS SUBSIDIARIESMETA | 12 | $44.9M |
| 4 | VISA INC.V | 45 | $37.7M |
| 5 |  AMAZON.COM SERVICES LLCAMZN | 36 | $32.8M |
| 6 |  LOCKHEED MARTIN CORPORATIONLMT | 73 | $29.0M |
| 7 |  FEDEX CORPORATIONFDX | 69 | $27.8M |
| 8 |  ELI LILLY AND COMPANYLLY | 56 | $27.1M |
| 9 |  ALTRIA CLIENT SERVICES LLCMO | 142 | $25.2M |
| 10 |  AMGEN INCAMGN | 19 | $24.9M |
| 11 |  COMCAST CORPORATIONCMCSV | 179 | $24.7M |
| 12 |  MERCK & CO INCMRK | 14 | $24.0M |
| 13 |  SOUTHERN COMPANYSO | 53 | $23.9M |
| 14 |  GOOGLE CLIENT SERVICES LLCGOOGL | 79 | $22.6M |
| 15 |  APPLE INCAAPL | 9 | $22.1M |
| 16 |  T-MOBILE USA INC.TMUS | 121 | $21.0M |
| 17 |  UNITEDHEALTH GROUP INCUNH | 19 | $20.4M |
| 18 |  VERIZON COMMUNICATIONS INC AND VARIOUS SUBSIDIARIESVZ | 40 | $20.1M |
| 19 |  OCCIDENTAL PETROLEUM CORPORATIONOXY | 30 | $19.7M |
| 20 |  MICROSOFT CORPORATIONMSFT | 103 | $18.8M |
| 21 |  QUALCOMM INCORPORATEDQCOM | 40 | $17.2M |
| 22 |  GENERAL DYNAMICS CORPGD | 11 | $17.0M |
| 23 |  BOEING COMPANYBA | 23 | $16.9M |
| 24 | THE CIGNA GROUP AND SUBSIDIARIES (FORMERLY CIGNA CORPORATION AND SUBSIDIARIES)CI | 13 | $16.9M |
| 25 |  ORACLE CORPORATIONORCL | 58 | $16.7M |
🎯 Top Lobbied Tickers
| # | Ticker | Filings | Total $ |
|---|---|---|---|
| 1 | META Meta Platforms Inc. | 129 | $50.2M |
| 2 | PFE Pfizer Inc. | 87 | $48.6M |
| 3 | GM General Motors Company | 103 | $48.4M |
| 4 | V Visa Inc. | 46 | $37.7M |
| 5 | AMZN Amazon.com Inc. | 80 | $35.3M |
| 6 | LMT Lockheed Martin Corporation | 88 | $29.4M |
| 7 | FDX FedEx Corporation | 82 | $28.3M |
| 8 | LLY Eli Lilly and Company | 83 | $28.1M |
| 9 | AMGN Amgen Inc. | 95 | $28.0M |
| 10 | MRK Merck & Co. Inc. | 92 | $27.5M |
| 11 | AAPL Apple Inc. | 64 | $26.8M |
| 12 | GOOGL Alphabet Inc. Class A | 123 | $26.6M |
| 13 | MO | 164 | $26.2M |
| 14 | SO Southern Company | 108 | $26.1M |
| 15 | UNH UnitedHealth Group Inc. | 67 | $23.9M |
| 16 | VZ Verizon Communications Inc. | 116 | $23.8M |
| 17 | TMUS | 159 | $22.7M |
| 18 |  CHTR | 137 | $22.6M |
| 19 | GD General Dynamics Corporation | 127 | $22.5M |
| 20 |  TAT&T Inc. | 134 | $21.6M |
| 21 | ORCL Oracle Corporation | 132 | $20.6M |
| 22 | CMCSA Comcast Corporation | 141 | $20.4M |
| 23 | CI The Cigna Group | 64 | $19.9M |
| 24 | OXY Occidental Petroleum Corporation | 36 | $19.9M |
| 25 | MSFT Microsoft Corporation | 122 | $19.2M |
🆕 Filtered Filings · ABBVIE
clear filters| Date | Ticker | Client | Registrant | Amount | Issue |
|---|---|---|---|---|---|
| 2026-04-20 | ABBV | ABBVIE | CAPITOL TAX PARTNERS, LLP | $80K | Legislative services related to corporate and international tax matters. |
| 2026-04-20 | ABBV | ABBVIE | ACG ADVOCACY | $60K | Trade Policy. Patent Legislation. Patent Review Procedures. |
| 2026-04-15 | ABBV | ABBVIE | BROWNSTEIN HYATT FARBER SCHRECK, LLP | $90K | Issues related to patient access, pharmaceutical manufacturing, Patent reform, and drug pricing both domestic and international Issues realted to medicare drug pricing and reimbursement DTC Advertising Issues related to potential privacy legislation |
| 2026-01-20 | ABBV | ABBVIE | ACG ADVOCACY | $60K | Trade Policy. Patent Legislation. Patent Review Procedures. Innovation Policy. |
| 2026-01-19 | ABBV | ABBVIE | CAPITOL TAX PARTNERS, LLP | $80K | Legislative services related to corporate and international tax matters. |
| 2026-01-13 | ABBV | ABBVIE | BROWNSTEIN HYATT FARBER SCHRECK, LLP | $80K | Issues related to patient access, pharmaceutical manufacturing, Patent reform, and drug pricing both domestic and international Issues realted to medicare drug pricing and reimbursement DTC Advertising Reciprocal tariffs |
| 2025-10-17 | ABBV | ABBVIE | CAPITOL TAX PARTNERS, LLP | $80K | Legislative services related to corporate and international tax matters and P.L. 119-21. |
| 2025-10-17 | ABBV | ABBVIE | ACG ADVOCACY | $80K | Trade Policy. |
| 2025-10-16 | ABBV | ABBVIE | BROWNSTEIN HYATT FARBER SCHRECK, LLP | $80K | Issues related to patient access, pharmaceutical manufacturing, Patent reform, and drug pricing both domestic and international Issues related to Medicare drug pricing and reimbursement DTC Advertising Reciprocal tariffs |
| 2025-07-21 | ABBV | ABBVIE | CAPITOL TAX PARTNERS, LLP | $80K | Legislative services related to corporate and international tax matters and H.R. 1, 2025 Budget Reconciliation Bill. |
| 2025-07-21 | ABBV | ABBVIE | ACG ADVOCACY | $30K | Trade Policy. |
| 2025-07-21 | ABBV | ABBVIE | ACG ADVOCACY | $0 | Trade Policy. |
| 2025-07-18 | ABBV | ABBVIE | BROWNSTEIN HYATT FARBER SCHRECK, LLP | $80K | Issues related to patient access, pharmaceutical manufacturing, Patent reform, and drug pricing both domestic and international Issues realted to medicare drug pricing and reimbursement Reciprocal Tariffs |
| 2025-04-21 | ABBV | ABBVIE | CAPITOL TAX PARTNERS, LLP | $80K | Legislative services related to corporate and international tax matters. |
| 2025-04-18 | ABBV | ABBVIE | BROWNSTEIN HYATT FARBER SCHRECK, LLP | $80K | Issues related to patient access, pharmaceutical manufacturing, Patent reform and drug pricing both domestic and international Issues related to Medicare drug pricing and reimbursement |
| 2025-01-20 | ABBV | ABBVIE | CAPITOL TAX PARTNERS, LLP | $60K | Legislative services related to corporate and international tax matters and H.R. 7024, Tax Relief for American Families and Workers Act of 2024. |
| 2025-01-20 | ABBV | ABBVIE | BROWNSTEIN HYATT FARBER SCHRECK, LLP | $60K | Issues related to patient access, pharmaceutical manufacturing, Patent reform, and drug pricing HELP Copays Act |